Protein corona change the drug release profile of nanocarriers: The "overlooked" factor at the nanobio interface

Colloids and Surfaces B: Biointerfaces

Volumn 123, Issue , 2014, Pages 143-149

  Behzadi, Shahed ^a   Serpooshan, Vahid ^b   Sakhtianchi, Ramin ^c   Müller, Beate ^a   Landfester, Katharina ^a   Crespy, Daniel ^a   Mahmoudi, Morteza ^b,c  

^a MAX PLANCK INSTITUTE FOR POLYMER RESEARCH   (Germany)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Drug release profile; Nanocarriers; Polymeric shell; Protein corona

Indexed keywords

BIOLOGY; DISEASE CONTROL; DRUG DELIVERY; DRUG PRODUCTS; FUNCTIONAL POLYMERS; NANOCAPSULES;

DRUG DELIVERY APPLICATIONS; DRUG RELEASE; NANO-CARRIERS; POLYMERIC NANOCAPSULES; POLYMERIC SHELL; PROTEIN CORONAS; STIMULI-RESPONSIVE POLYMER; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLES;

PROTEINS;

NANOCAPSULE; NANOCARRIER; PACLITAXEL; POLYMER; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; TAMOXIFEN CITRATE;

ARTICLE; CONJUGATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG RELEASE; IN VIVO STUDY; NANOBIOTECHNOLOGY; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN STRUCTURE;

EID: 84915785368     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2014.09.009     Document Type: Article

References (30)

1. Bowman D., Hodge G. A small matter of regulation: an international review of nanotechnology regulation. Columbia Sci. Technol. Law Rev. 2007, 8:1-32.
2. Kan S., Mokari T., Rothenberg E., Banin U. Synthesis and size-dependent properties of zinc-blende semiconductor quantum rods. Nat. Mater. 2003, 2:155-158.
3. Laurent S., Burtea C., Thirifays C., Rezaee F., Mahmoudi M. Significance of cell observer and protein source in nanobiosciences. J. Colloid Interface Sci. 2013, 392:431-445.
4. Mahmoudi M., Hofmann H., Rothen-Rutishauser B., Petri-Fink A. Assessing the in vitro and in vivo toxicity of superparamagnetic iron oxide nanoparticles. Chem. Rev. 2012, 112:2323.
5. Hajipour M.J., Fromm K.M., Akbar Ashkarran A., Jimenez de Aberasturi D., Larramendi I.R.D., Rojo T., Serpooshan V., Parak W.J., Mahmoudi M. Antibacterial properties of nanoparticles. Trends Biotechnol. 2012, 30:499-511.
6. Alivisatos P. The use of nanocrystals in biological detection. Nat. Biotechnol. 2003, 22:47-52.
7. Horcajada P., Chalati T., Serre C., Gillet B., Sebrie C., Baati T., Eubank J.F., Heurtaux D., Clayette P., Kreuz C. Porous metal-organic-framework nanoscale carriers as a potential platform for drug delivery and imaging. Nat. Mater. 2009, 9:172-178.
8. Alvarez-Erviti L., Seow Y., Yin H., Betts C., Lakhal S., Wood M.J.A. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat. Biotechnol. 2011, 29:341-345.
9. Ashley C.E., Carnes E.C., Phillips G.K., Padilla D., Durfee P.N., Brown P.A., Hanna T.N., Liu J., Phillips B., Carter M.B., Carroll N.J., Jiang X., Dunphy D.R., Willman C.L., Petsev D.N., Evans D.G., Parikh A.N., Chackerian B., Wharton W., Peabody D.S., Brinker C.J. The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers. Nat. Mater. 2011, 10:389-397.
10. Cai D., Mataraza J.M., Qin Z.H., Huang Z., Huang J., Chiles T.C., Carnahan D., Kempa K., Ren Z. Highly efficient molecular delivery into mammalian cells using carbon nanotube spearing. Nat. Methods 2005, 2:449-454.
11. Horcajada P., Chalati T., Serre C., Gillet B., Sebrie C., Baati T., Eubank J.F., Heurtaux D., Clayette P., Kreuz C., Chang J.S., Hwang Y.K., Marsaud V., Bories P.N., Cynober L., Gil S., Férey G., Couvreur P., Gref R. Porous metal-organic-framework nanoscale carriers as a potential platform for drug deliveryand imaging. Nat. Mater. 2010, 9:172-178.
12. Lynch I., Salvati A., Dawson K.A. Protein-nanoparticle interactions: what does the cell see?. Nat. Nanotechnol. 2009, 4:546-547.
13. Monopoli M.P., Åberg C., Salvati A., Dawson K.A. Biomolecular coronas provide the biological identity of nanosized materials. Nat. Nanotechnol. 2012, 7:779-786.
14. Mahmoudi M., Lynch I., Ejtehadi M.R., Monopoli M.P., Bombelli F.B., Laurent S. Protein-nanoparticle interactions: opportunities and challenges. Chem. Rev. 2011, 111:5610-5637.
15. Monopoli M.P., Walczyk D., Campbell A., Elia G., Lynch I., Baldelli Bombelli F., Dawson K.A. Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. J. Am. Chem. Soc. 2011, 133:2525-2534.
16. Walczyk D., Bombelli F.B., Monopoli M.P., Lynch I., Dawson K.A. What the cell "sees" in bionanoscience. J. Am. Chem. Soc. 2010, 132:5761-5768.
17. Mahmoudi M., Lohse S.E., Murphy C.J., Fathizadeh A., Montazeri A., Suslick K.S. Variation of protein corona composition of gold nanoparticles following plasmonic heating. Nano Lett. 2014, 14:6-12.
18. Mahmoudi M., Laurent S., Shokrgozar M.A., Hosseinkhani M. Toxicity evaluations of superparamagnetic iron oxide nanoparticles: cell "vision" versus physicochemical properties of nanoparticles. ACS Nano 2011, 5:7263-7276.
19. Amiri H., Saeidi K., Borhani P., Manafirad A., Ghavami M., Zerbi V. Alzheimer's disease: pathophysiology and applications of magnetic nanoparticles as MRI theranostic agents. ACS Chem. Neurosci. 2013, 4:1417-1429.
20. Salvati A., Pitek A.S., Monopoli M.P., Prapainop K., Bombelli F.B., Hristov D.R., Kelly P.M., Åberg C., Mahon E., Dawson K.A. Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. Nat. Nanotechnol. 2013, 8:137-143.
21. Mirshafiee V., Mahmoudi M., Lou K., Cheng J., Kraft M.L. Protein corona significantly reduces active targeting yield. Chem. Commun. 2013, 49:2557-2559.
22. Mahmoudi M., Monopoli M.P., Rezaei M., Lynch I., Bertoli F., McManus J.J., Dawson K.A. The protein corona mediates the impact of nanomaterials and slows amyloid beta fibrillation. ChemBioChem 2013, 14:568-572.
23. Mahmoudi M., Simchi A., Imani M., Häfeli U.O. Superparamagnetic iron oxide nanoparticles with rigid cross-linked polyethylene glycol fumarate coating for application in imaging and drug delivery. J. Phys. Chem. C 2009, 113:8124-8131.
24. Park J., An K., Hwang Y., Park J., Noh H., Kim J., Park J., Hwang N., Hyeon T. Ultra-large-scale syntheses of monodisperse nanocrystals. Nat. Mater. 2004, 3:891-895.
25. Xu Y., Qin Y., Palchoudhury S., Bao Y. Water-soluble iron oxide nanoparticles with high stability and selective surface functionality. Langmuir 2011, 27:8990-8997.
26. Nienhaus G., Maffre P., Nienhaus K. Studying the protein corona on nanoparticles by FCS. Methods Enzymol. 2012, 519:115-137.
27. MacEachern-Keith G.J., Wagner Butterfield L.J., Incorvia Mattina M.J. Paclitaxel stability in solution. Anal. Chem. 1997, 69:72-77.
28. Chin A., Ramakrishnan R.R., Yoshimura N.N., Jeong E.W.S., Nii L.J., DiMeglio L.S. Paclitaxel stability and compatibility in polyolefin containers. Ann. Pharmacother. 1994, 28:35-36.
29. Waugh W.N., Trissel L.A., Stella V.J. Stability, compatibility, and plasticizer extraction of taxol (NSC-125973) injection diluted in infusion solutions and stored in various containers. Am. J. Hosp. Pharm. 1991, 48:1520-1524.
30. ®) in human plasma. J. Chromatogr. B: Biomed. Sci. Appl. 1993, 621:231-238.